An increased risk of ESRD has been reported for living kidney donors, and appears to be higher for those donating to a relative. The reasons for this are not clear. One possibility is that ESRD is due to the nephrectomy-related reduction in GFR, followed by an age-related decline that may be more rapid in related donors. 
| INTRODUCTION
A living kidney donor loses about 50% of kidney function with unilateral nephrectomy. The remaining kidney undergoes compensatory hypertrophy, and within 6 weeks of donor nephrectomy, glomerular filtration rate (GFR) returns to approximately 70% of preoperative values. It has been thought that, in the short term, there may be an additional small GFR improvement, followed by stabilization. However, during middle age, some individuals experience a slow, but steady, decline in GFR. If kidney function is normal at the beginning of this decline, it rarely leads to development of end-stage renal disease (ESRD).
It was long believed, based on long-term clinical observations comparing donors to the general population, that living kidney donors had sufficient renal function to withstand this decline in GFR and to live a normal life without increased risk of ESRD. [1] [2] [3] [4] However, two recent studies comparing donors with matched healthy controls, have suggested that donors have a slightly increased lifetime risk of ESRD. 5, 6 In those two studies, the majority of ESRD was seen in those donating to a relative. Confounding this observation is that, in the absence of donation, relatives of those with ESRD are at increased risk of developing ESRD. [7] [8] [9] [10] [11] [12] [13] Additionally, in the first few decades of clinical transplantation, most donors were related to their recipient, so that, in general, related donors have longer follow-up than unrelated donors.
14 An understanding of the pathogenesis of, and risk factors for, ESRD in donors is important for donor selection and counseling. For some, nephrectomy might not leave sufficient reserve for the "normal" agerelated decline in GFR. It is also possible that donors might experience a more rapid decline in kidney function than observed in nondonors. A Abbreviations: eGFR, estimated glomerular filtration rate; ESRD, end stage renal disease.
third possibility is that donors experience the same steady decline in GFR as seen in nondonors, but that some develop new-onset kidney or systemic disease that accelerates the decline in GFR.
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Determining whether (postdonation) normal age-related GFR decline, alone, explains the increased risk of ESRD is important for counseling potential donors; if so, a higher GFR threshold at evaluation could be considered, especially in younger donors. It would also be important to determine whether donors having a relative with ESRD had a faster decline in eGFR compared to those without. If the increased risk is limited to those having a relative with ESRD, then those without a relative with ESRD could be counseled that they may not be at increased risk.
In this study, we analyzed estimated GFR (eGFR) over time in 2002
white kidney donors to determine: (1) whether the typical decline in eGFR over time can explain the increased rate of ESRD in donors, and (2) whether slope differs between those donating to a first-degree relative with ESRD (or having a first-degree relative with ESRD) and donors without a first-degree relative with ESRD.
| MATERIALS AND METHODS
We have a longstanding, institutional review board (IRB)-approved study of long-term kidney donor outcomes (IRB HSC# 0301M39762).
Our protocols have been described in detail. to undergo a routine health checkup, including laboratory tests. All information is entered into our IRB-approved database.
| Study cohort and outcomes
Because donors at our institution are primarily white, and because ESRD rates differ by ethnicity, we limited our analysis to whites. and those without a first-degree relative with ESRD (n = 757) (donated to 640 unrelated recipients; 117 to distant relatives).
The primary outcome of our study was eGFR, estimated using the CKD-EPI equation. 20 Measurements of eGFR within 6 weeks postdonation were excluded from the analysis because the goal was to model longterm trends in kidney function and not transient changes. 
| Statistical analyses

| RESULTS
| Donor characteristics
Donors with a first-degree relative with ESRD were younger (P < .001), donated during an earlier era (P < .001), were more likely to be male (P = .057), and were more likely to be smokers at the time of donation (P < .001) ( Table 1) . Also, donors with a first-degree relative with ESRD had longer follow-up (median, 10.0 years vs. 6.1 years, P < .001) but a similar number of eGFR measurements postdonation (median, 4 vs.
3 measurements). Other characteristics were similar between groups. 
| Longitudinal model of postdonation eGFR
| Impact of having a first-degree relative with ESRD
The average eGFR trajectory for donors with and without a firstdegree relative with ESRD at different ages at donation (holding all other factors constant) is shown in Figure 2A . Figure 2B shows the standard error for the estimated mean eGFR at various timepoints. In our additional analyses of the cohort of donors of all races and of the entire white cohort (since 1963), the findings were similar to those modeled above (Tables S1-S4 , Figures S1 and S2 in the Supplementary Appendix).
| Impact of donation age and attained age
Even after controlling for the effects of predonation eGFR, we found a statistically significant association between older donation age and decreased postdonation eGFR (Figure 2 ). For example, a 55-year-old donor could expect postdonation eGFR on average to be 8.34 mL/ min/1.73 m 2 lower than that of a 25-year-old donor if other characteristics were held constant (95% CI 6.97-9.72; P < .001). Once donors reached age 70, they had an average yearly decline in eGFR of 0.38 mL/ min/1.73 m 2 (0.09-0.67) more than those <70 years old.
| Other factors
Female gender more recent donation, and a lower predonation body mass index (BMI) were all associated with increased eGFR postdonation (P < .01 for all covariates).
T GFR, estimated per the CKD-EPI formula using serum creatinine. c Follow-up is defined as the time from donation until the last serum creatinine measurement.
BMI, body mass index; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; GFR, glomerular filtration rate.
| DISCUSSION
ESRD is a rare event after living kidney donation. A decline in GFR, which precedes ESRD, is much more common; therefore, focusing on eGFR allows for greater power to detect differences by family history of ESRD. Our data suggest that the normal age-related decline in GFR is not responsible for any increased risk of postdonation ESRD. Given the average rate of decline in GFR over time for donors with and without a first-degree relative with ESRD, it would take a prolonged time to develop a GFR time. 21 In the donor cohort we describe herein (ie, our donors since 1990), only 3 donors have developed ESRD. However, in our entire donor cohort since 1963, a total of 39 donors have developed ESRD. Again, similar to the study by Kido et al, we found that for these 39, serum creatinine levels (eGFR) remained stable until the development of new disease.
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Steiner et al argue that nondonors with normal (for age) renal function who develop new-onset disease later in life (eg, type 2 diabetes) might have a disease-related decline in kidney function; but with sufficient renal reserve that decline would not necessarily result in ESRD.
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However, the same decline in donors with less reserve might result in 
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Our findings suggest that eGFR trends postdonation might not be able to be extrapolated from population data of nondonors as advocated. First, irrespective of age at donation, eGFR on average steadily increased for the subsequent few years (Figures 1 and 2) . After that GFR, estimated using the CKD-EPI formula using serum creatinine. BMI, body mass index; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; GFR, glomerular filtration rate; y, years; Hx, history; SE, standard error; wk, weeks. 
A B
(maximum follow-up, 25.8 years), there was a slower continuing increase in eGFR for younger donors; but for older donors (eg, ≥55 years old), GFR stabilized and then declined once the donor reached 70 years of age. An increasing eGFR in the first few years postdonation has previously been reported. [25] [26] [27] [28] [29] [30] In a study with short follow-up, Cho et al, using serial 99 mTc-diethylenetriaminepentaacetic acid scans over 2 years postdonation, found increasing GFR. 25 In a prospective study of donors and matched controls, Kasiske et al reported that, over a period of 3 years, the mean (SD) slope of the measured GFR (mGFR) was +1.47 (5.02) mL/min/year in donors, but was −0.36 (7.55) mL/min/ year in controls (P = .005). 26 Similarly, Lenihan et al, studying postdonation glomerular dynamics, reported increased plasma flow and GFR over 6 years. 27 Although also finding an increase in measured GFR for the first 5 years after donation, Courbebaisse et al found that both age and BMI at donation were inversely correlated with the change in GFR. 28 Similarly, we found that both age and BMI at donation, were inversely correlated with postdonation eGFR (Figure 2A ). . 30 They found that, for a 30-year-old donor, the median GFR increased for the first 17 years, remained stable ~8 years, and then began a slow decline. In contrast, for a 50-year-old donor, the median GFR increased for ~15 years and then slowly fell. Combined with our data, this information suggests that GFR increases for many years postdonation, and that once the age-related fall in GFR begins, donors have more reserve than population data might suggest.
As a consequence, a higher GFR threshold in younger donors might not be necessary.
Our analyses were limited to white donors from 1990 through 2014. Although our donors before 1990 do have longer follow-up, surveillance was less frequent during that era, so only a limited number of serum creatinine levels were documented in the database. For a sensitivity analysis, we reanalyzed our data using all white donors from 1963 through 2014 (see Supplementary Appendix S1). We found no substantive differences in the results between the study cohorts.
Importantly, we occasionally performed unrelated donor nephrectomy in the first decades of clinical kidney transplantation; however, it only became common after the mid-1980s. 14 In our dataset, related donors were more likely to have donated earlier in the history of our program. Given this imbalance, we included donation year in our statistical model, thereby accounting for any secular trends in donor care or donor selection. Familial-related development of postdonation hypertension or type 2 diabetes might have accounted for the difference in slope between related and unrelated donors. We found no postdonation differences between groups in the incidence of those diagnoses (Tables S5-S6 in the Supplemental Appendix). Of note, since the vast majority of our donor population is white, we limited our analyses to whites. In the general population as well as the donor population, blacks and Hispanics have increased rates of ESRD, as compared with whites. 18 For a sensitivity analysis, we reanalyzed our data using donors from all racial groups (see Supplementary Appendix S2). We found no significant differences in the postdonation eGFR trajectory between whites and nonwhites, but our observations need to be validated in larger nonwhite donor populations. In our analyses, we compared donors with and without a known first-degree relative with ESRD. Of the 757 donors without a first-degree relative with ESRD, the majority 640 (84%) were unrelated. The subgroup of 117 who donated to distant relatives was too small for independent analysis. Removing that subgroup from the analysis did not affect the results. We found a smaller annual increase in GFR for related (vs. unrelated) donors (and subsequently a slightly greater decline). Although our data suggests that the age-related fall in GFR is unlikely a cause of ESRD in either group, 
